The Company recently presented three posters at the Society for Immunotherapy of Cancer (SITC) 39 th Annual Meeting held in Houston, TX and virtually: Discovery of a MAGE-A4-specific TCR-T Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback